Novo Nordisk to acquire Forma Therapeutics in USD 1.1bn deal
![Photo: Stine Tidsvilde](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14354076.ece/ALTERNATES/schema-16_9/doc7mj0bbnud1e1kklpk1g1.jpg)
Novo Nordisk has inked a definitive deal with Forma Therapeutics, whereby the Danish firm will pay USD 20 for all outstanding shares in the US-based biotech firm, amounting to a total price of USD 1.1bn, a press release announced on Thursday.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Four new products will help Novo Nordisk division grow
For subscribers
Novo Nordisk to start human trial of new diabetes drug
For subscribers
Novo Nordisk enters USD 6.3m legal settlement in US
For subscribers